4/25
02:00 am
indv
Indivior Announces Q1 2024 Financial Results
Medium
Report
Indivior Announces Q1 2024 Financial Results
4/25
02:00 am
indv
Indivior Announces Q1 2024 Financial Results
Medium
Report
Indivior Announces Q1 2024 Financial Results
4/3
08:11 am
indv
Indivior PLC (NASDAQ: INDV) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $37.00 price target on the stock.
Medium
Report
Indivior PLC (NASDAQ: INDV) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $37.00 price target on the stock.
3/11
02:43 pm
indv
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone
Medium
Report
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone
2/29
02:02 am
indv
Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation
Low
Report
Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation
2/22
02:00 am
indv
Indivior Announces Q4 / FY 2023 Financial Results
High
Report
Indivior Announces Q4 / FY 2023 Financial Results
2/22
02:00 am
indv
Indivior Announces Q4 / FY 2023 Financial Results
High
Report
Indivior Announces Q4 / FY 2023 Financial Results